Script Help has secured three new partnerships for its new software program as a service (SaaS) medical hashish prescription administration platform, simply weeks after launching.
UK medical hashish clinics Integro and Cannim, together with IPS Pharmacy, are the newest to utilise Script Help’s expertise, following intently within the footsteps of CB1 Medical and Jersey-based clinic Medican.
As the corporate prepares to increase its footprint into new markets and produce much more companions on board within the UK, Script Help’s CEO Ben Hamburger advised Enterprise of Hashish: “We’re thrilled to increase our attain with these new companions. Every partnership highlights the flexibility and power of Script Help’s expertise, tailor-made to satisfy various wants within the business.”
What occurred?
Final month, Enterprise of Hashish reported that Script Help’s medical hashish expertise platform, which goals to allow an environment friendly medical hashish journey for clinics, medical doctors, and sufferers, was launching on a software program as a service (SaaS) foundation for the primary time.
Ever since, its consumer roster has expanded quickly, with plenty of additional partnerships with large medical hashish gamers set to be introduced within the coming weeks.
Its new partnerships with Integro Clinics and IPS Pharmacy will see its expertise, which may be absolutely customised and tailor-made to the consumer’s particular person wants, built-in into their patient-facing platforms.
A consultant from Integro Clinics mentioned: “We’re excited to announce our partnership with Script Help, which is able to revolutionise affected person care at Integro Clinics. Our bespoke app will allow sufferers to effortlessly submit enquiries, ebook and be a part of consultations, and allow expedient processing of their prescriptions.
“With correct monitoring and seamless digital funds, we’re set to reinforce the affected person expertise considerably. This collaboration underscores our dedication to delivering excellent healthcare throughout the UK.”
IPS Pharmacy acknowledged: “IPS Pharmacy is proud to announce our partnership with Script Help, which is able to vastly improve affected person entry to medical hashish. By way of our bespoke app, sufferers will view exact stock availability ranges, make funds, and monitor their orders with full accuracy.
“This integration ensures full transparency and ease of entry to their medicine. As an organisation devoted to assembly the unmet medicinal wants of sufferers and leaders in healthcare innovation, we’re excited to supply this enhanced service, offering superior care to sufferers throughout the UK.”
For Cannim, Script Help’s full platform, together with prescription monitoring and stock administration, shall be built-in to assist help the launch of a brand new UK clinic.
Cannim’s UK Industrial Supervisor, Tim Henley, mentioned: “Cannim are delighted to announce after a protracted exhaustive choice course of that the Script Help staff and platform have been chosen to construct our really distinctive and progressive UK Hashish clinic launching in September. Ben and Arjun together with the whole staff at Script Help have been extremely attentive to our wants.
“Cannim are constructing a very science-led method to the personalised well being and wellness house and completely consider our partnership with Script Help shall be transformational within the space. Watch this house for our launch.”
Wanting forward
In line with new figures from the UK’s Care High quality Fee (CQC), the variety of prescriptions for unlicensed medical hashish in England greater than doubled final 12 months.
‘The safer administration of managed medicine: annual replace 2023’, printed earlier this month, exhibits that 177,566 cannabis-based merchandise have been prescribed between July 01, 2022 and June 30, 2023, up from 81,476 objects in the identical interval a 12 months earlier.
To satisfy this rising demand, Mr Hamburger means that the answer lies in driving higher effectivity within the nation’s present medical hashish infrastructure, moderately than opening extra clinics.
He defined: “As we see it, the issue for the business doesn’t lie in an inadequate variety of clinics or healthcare suppliers to satisfy affected person demand, however moderately in enabling these clinics to serve excessive volumes of sufferers with out sacrificing affected person care. That’s the issue we selected to resolve.
“Essentially we wish this sector to thrive and develop – and that requires improved affected person and clinic expertise. We would like our companions to do nicely and work intently with them to just do that; our platform’s flexibility permits it to adapt to altering wants and operational processes, making it a long-term answer for our companions.”
Slightly than put aside appreciable time and capital expenditure on constructing a proprietary platform, one thing Mr Hamburger suggests is ‘expensive, time-consuming and fraught with dangers’, he believes clinics are actually coming round to the concept of utilizing third-party expertise.
“The market is recognising the worth of subtle, dependable tech options for medical hashish. The complexities of regulatory compliance, stock administration, and affected person care require greater than only a fundamental software program bundle,” he continues.
“The commonest grievance you hear from sufferers is that the info offered to them through a portal or an Excel file merely isn’t correct. Over the subsequent couple of months, for a considerable proportion of the present affected person inhabitants, that drawback shall be a factor of the previous.
“Sufferers can have exact transparency of what’s accessible once they request a repeat, and no matter they request is immutably reserved for them. That change alone goes to really feel as if the UK’s medical hashish market is modernising and maturing.”
